FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 88 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,351,000 | +18.9% | 294,379 | +0.4% | 0.04% | +37.0% |
| Q3 2019 | $1,136,000 | -35.8% | 293,206 | -0.1% | 0.03% | -28.9% |
| Q2 2019 | $1,770,000 | -28.5% | 293,614 | +58.8% | 0.04% | -29.6% |
| Q1 2019 | $2,477,000 | -6.6% | 184,848 | -35.2% | 0.05% | -21.7% |
| Q4 2018 | $2,653,000 | -35.8% | 285,237 | -3.7% | 0.07% | -19.8% |
| Q3 2018 | $4,132,000 | +535.7% | 296,339 | +615.4% | 0.09% | +616.7% |
| Q2 2018 | $650,000 | +104.4% | 41,423 | +292.1% | 0.01% | +100.0% |
| Q2 2017 | $318,000 | -76.5% | 10,565 | -71.7% | 0.01% | -81.8% |
| Q1 2017 | $1,351,000 | -60.8% | 37,361 | -45.7% | 0.03% | -73.2% |
| Q4 2016 | $3,449,000 | +23.6% | 68,826 | +29.5% | 0.12% | +43.0% |
| Q3 2016 | $2,790,000 | -35.3% | 53,148 | -49.0% | 0.09% | -39.4% |
| Q2 2016 | $4,309,000 | -22.4% | 104,202 | -23.8% | 0.14% | -10.7% |
| Q1 2016 | $5,556,000 | +347.7% | 136,743 | +358.2% | 0.16% | +448.3% |
| Q4 2015 | $1,241,000 | – | 29,842 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|